Wolverine Asset Management’s Aegerion Pharmaceuticals AEGR Stock Holding History

Wolverine Asset Management’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-13,354	Closed	-$39K	–	1442
2016 Q3	$39K	Hold	13,354	–	–	﹤0.01%	1082
2016 Q2	$19K	Buy	+13,354	New	+$30.5K	﹤0.01%	1105

Wolverine Asset Management's AEGR Position: Q4 2016 in Review

Wolverine Asset Management sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 13,354 shares — an estimated $39K sold.

Wolverine Asset Management first reported a position in AEGR in Q2 2016 and held it in 2 quarters. The position peaked at $39K in Q3 2016. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

Wolverine Asset Management reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Wolverine Asset Management sold 13,354 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $39K.
Wolverine Asset Management first reported a position in Aegerion Pharmaceuticals in Q2 2016 and held it in 2 quarters.
Wolverine Asset Management's Aegerion Pharmaceuticals position peaked at $39K in Q3 2016.
0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Wolverine Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.